The biguanide metformin is one of the mostly used drugs for treatment of type 2 diabetes.
二甲双胍是一种胰岛素增敏剂，多年来被广泛应用于对2型糖尿病患者的降血糖治疗。
Metformin hydrochloride is an orally administered biguanide widely used in clinical medicine.
盐酸二甲双胍是目前广泛用于临床医学的双胍类降糖药。
The biguanide metformin is believed to lower plasma glucose without affecting insulin secretion.
目前认为双胍类药物二甲双胍降低血糖但不不影响胰岛素分泌。
The invention discloses a biguanide anti-diabetes medicine, in particular to a metformin hydrochloride enteric-coated medicine compound.
本发明公开了一种双胍类抗糖尿病药物，特别是盐酸二甲双胍的肠溶药物组合物。
The composite can avoid the interaction of biguanide medicine and sulfonylurea medicine and improves the treatment effect and the stability of the composite.
该组合物可避免双胍类药物与磺酰脲药物的相互作用，提高组合物的治疗效果和稳定性。
The composite can avoid the interaction of biguanide medicine and sulfonylurea medicine and improves the treatment effect and the stability of the composite.
该组合物可避免双胍类药物与磺酰脲药物的相互作用，提高组合物的治疗效果和稳定性。
应用推荐